---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-029326"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2026-01-29T23:59:59+00:00"
generated_at: "2026-05-16T06:49:58.392695+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q2 FY2026: Revenue $1.42B (+11% YoY), non-GAAP EPS $2.81, dividend $0.60

## Summary
- Revenue $1,422.8M, up 11% YoY (9% constant currency); gross margin expanded 320 bps to 61.8%.
- GAAP diluted EPS $2.68; non-GAAP diluted EPS $2.81, up 16% YoY.
- Operating cash flow $340M; income from operations rose 18% YoY.
- Board declared quarterly cash dividend of $0.60/share, record Feb 12, payable Mar 19.

## SEC filing metadata
- accession: 0001193125-26-029326
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2026-01-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/0001193125-26-029326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/d80310d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-029326
- JSON: https://secwatch.observer/filing/0001193125-26-029326.json
- Plain text: https://secwatch.observer/filing/0001193125-26-029326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.